Recent news on Vivelle-Dot

Noven Reports First Quarter 2007 Financial Results  -  Apr 30, 2007
Teleborsa News,...“Sales of our Vivelle-Dot ® and Daytrana™ products contributed to a 90% increase in first quarter revenues. This increase in revenues, together with a

Noven Announces First Quarter 2007 Earnings Release Date  -  Apr 23, 2007
Genetic Engineering News (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Noven to Present at Deutsche Bank Annual Health Care Conference  -  Apr 25, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Noven to Present at Deutsche Bank Annual Health Care Conference  -  Apr 25, 2007
Genetic Engineering News (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Noven to Present at Deutsche Bank Annual Health Care Conference  -  Apr 25, 2007
Business Wire (press release),Noven’s prescription patches are approved in over 30 countries and include Vivelle-Dot ® (the most prescribed estrogen patch in the US) and Daytrana™ (the

Noven Announces 2006 Financial Results  -  Mar 2, 2007
PharmaLive.com (press release),Thanks to growth in our Vivelle-Dot(R) estrogen patch and an outstanding effort by our sales force, the Novogyne joint venture had a record year.

Noven to Present at Lehman Brothers Global Healthcare Conference  -  Mar 14, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Hormones seen less risky in patch or gel  -  Feb 27, 2007
Newsday,The most popular brands include Climara, made by Berlex of Wayne, NJ, and Vivelle-Dot from Novogyne, a joint venture of Novartis and Noven Pharmaceuticals.

Noven Announces 2006 Earnings Release Date and Upcoming Investor ...  -  Feb 23, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Noven Receives $25 Million Daytrana Sales Milestone  -  Feb 21, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Hormone patch shows benefit over pill  -  Feb 21, 2007
Press-Enterprise (subscription),...tan or clear patches aren't widely used in the US The most popular brands include Climara, made by Berlex of Wayne, NJ, and Vivelle-Dot from Novogyne,

Risa Bernstein, Agency Co-Founder, Returns to Flashpoint Medica  -  Jan 17, 2007
PharmaLive.com (press release),Enzon for Abelcet, an IV anti-fungal agent, Novogyne (Noven and Novartis) for Vivelle Dot (estradiol transdermal system), a hormone replacement patch,

Noven Provides Update on Daytrana Methylphenidate Transdermal System  -  Nov 29, 2006
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional